On June 3, 2024, Medtronic, Inc., a subsidiary of Medtronic plc, issued €3B in senior notes across four tranches: €850M 3.650% due 2029, €850M 3.875% due 2036, €600M 4.150% due 2043, and €700M 4.150% due 2053. The notes are fully guaranteed by Medtronic Global Holdings S.C.A. and Medtronic plc. Net proceeds of approximately €2.97B are expected to be used for general corporate purposes, including debt repayment.The notes were issued under an indenture dated December 10, 2014, as supplemented. They rank equally with Medtronic, Inc.'s other unsecured senior indebtedness. The company has the option to redeem the notes prior to maturity under specified conditions. Medtronic plc has applied to list each series of notes on the New York Stock Exchange.The offering's financial impact was reflected in Medtronic plc's fiscal year 2025 adjusted EPS guidance announced on May 23, 2024. The underwriting agreement was signed on May 29, 2024, with Citigroup Global Markets Limited, J.P. Morgan Securities plc, Merrill Lynch International, and Mizuho International plc acting as representatives.

On June 3, 2024, Medtronic, Inc., a subsidiary of Medtronic plc, issued €3B in senior notes across four tranches: €850M 3.650% due 2029, €850M 3.875% due 2036, €600M 4.150% due 2043, and €700M 4.150% due 2053. The notes are fully guaranteed by Medtronic Global Holdings S.C.A. and Medtronic plc. Net proceeds of approximately €2.97B are expected to be used for general corporate purposes, including debt repayment.The notes were issued under an indenture dated December 10, 2014, as supplemented. They rank equally with Medtronic, Inc.'s other unsecured senior indebtedness. The company has the option to redeem the notes prior to maturity under specified conditions. Medtronic plc has applied to list each series of notes on the New York Stock Exchange.The offering's financial impact was reflected in Medtronic plc's fiscal year 2025 adjusted EPS guidance announced on May 23, 2024. The underwriting agreement was signed on May 29, 2024, with Citigroup Global Markets Limited, J.P. Morgan Securities plc, Merrill Lynch International, and Mizuho International plc acting as representatives.